##gff-version 3
##sequence-region O95863 1 264
O95863	UniProtKB	Chain	1	264	.	.	.	ID=PRO_0000047029;Note=Zinc finger protein SNAI1	
O95863	UniProtKB	Zinc finger	154	176	.	.	.	Note=C2H2-type 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
O95863	UniProtKB	Zinc finger	178	202	.	.	.	Note=C2H2-type 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
O95863	UniProtKB	Zinc finger	208	230	.	.	.	Note=C2H2-type 3;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
O95863	UniProtKB	Zinc finger	236	259	.	.	.	Note=C2H2-type 4%3B atypical;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
O95863	UniProtKB	Region	1	20	.	.	.	Note=SNAG domain;Ontology_term=ECO:0000250;evidence=ECO:0000250	
O95863	UniProtKB	Region	10	40	.	.	.	Note=LATS2 binding	
O95863	UniProtKB	Region	120	151	.	.	.	Note=Required for FBXL14-triggered degradation	
O95863	UniProtKB	Region	151	264	.	.	.	Note=Required for nuclear localization and interaction with KPNB1%2C NOTCH1 and PARP1;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21577210,ECO:0000269|PubMed:22128911;Dbxref=PMID:21577210,PMID:22128911	
O95863	UniProtKB	Motif	95	100	.	.	.	Note=Destruction motif	
O95863	UniProtKB	Compositional bias	90	120	.	.	.	Note=Ser-rich	
O95863	UniProtKB	Modified residue	11	11	.	.	.	Note=Phosphoserine%3B by PKA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19923321;Dbxref=PMID:19923321	
O95863	UniProtKB	Modified residue	82	82	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19923321;Dbxref=PMID:19923321	
O95863	UniProtKB	Modified residue	92	92	.	.	.	Note=Phosphoserine%3B by CK2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19923321;Dbxref=PMID:19923321	
O95863	UniProtKB	Modified residue	96	96	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269,ECO:0000305;evidence=ECO:0000269|PubMed:20305697,ECO:0000305|PubMed:15448698;Dbxref=PMID:20305697,PMID:15448698	
O95863	UniProtKB	Modified residue	100	100	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:15448698;Dbxref=PMID:15448698	
O95863	UniProtKB	Modified residue	104	104	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000305;evidence=ECO:0000269|PubMed:15647282,ECO:0000269|PubMed:19923321,ECO:0000305|PubMed:15448698;Dbxref=PMID:15647282,PMID:19923321,PMID:15448698	
O95863	UniProtKB	Modified residue	107	107	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000305;evidence=ECO:0000269|PubMed:15647282,ECO:0000269|PubMed:19923321,ECO:0000305|PubMed:15448698;Dbxref=PMID:15647282,PMID:19923321,PMID:15448698	
O95863	UniProtKB	Modified residue	111	111	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:15448698;Dbxref=PMID:15448698	
O95863	UniProtKB	Modified residue	115	115	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:15448698;Dbxref=PMID:15448698	
O95863	UniProtKB	Modified residue	119	119	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:15448698;Dbxref=PMID:15448698	
O95863	UniProtKB	Modified residue	203	203	.	.	.	Note=Phosphothreonine%3B by LATS2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21952048;Dbxref=PMID:21952048	
O95863	UniProtKB	Modified residue	246	246	.	.	.	Note=Phosphoserine%3B by PAK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15833848;Dbxref=PMID:15833848	
O95863	UniProtKB	Glycosylation	112	112	.	.	.	Note=O-linked (GlcNAc) serine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20959806;Dbxref=PMID:20959806	
O95863	UniProtKB	Cross-link	98	98	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)	
O95863	UniProtKB	Cross-link	137	137	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)	
O95863	UniProtKB	Cross-link	146	146	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)	
O95863	UniProtKB	Natural variant	66	66	.	.	.	ID=VAR_069162;Note=A->V;Dbxref=dbSNP:rs34261470	
O95863	UniProtKB	Natural variant	118	118	.	.	.	ID=VAR_019969;Note=V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11245431;Dbxref=dbSNP:rs4647958,PMID:11245431	
O95863	UniProtKB	Mutagenesis	2	2	.	.	.	Note=Abolishes repressor activity on E-cadherin/CDH1 promoter and binding to KDM1A. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20562920;Dbxref=PMID:20562920	
O95863	UniProtKB	Mutagenesis	9	9	.	.	.	Note=Does not affect E-cadherin/CDH1 repression%3B when associated with R-16. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16096638;Dbxref=PMID:16096638	
O95863	UniProtKB	Mutagenesis	11	11	.	.	.	Note=Abolishes PKA phosphorylation. Strongly decreases repressor activity on E-cadherin/CDH1 and CLDN1 promoters. Increases protein stability. Affects function in EMT. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19923321;Dbxref=PMID:19923321	
O95863	UniProtKB	Mutagenesis	16	16	.	.	.	Note=Does not affect E-cadherin repression%3B when associated with R-9. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16096638;Dbxref=PMID:16096638	
O95863	UniProtKB	Mutagenesis	92	92	.	.	.	Note=Abolishes CK2 phosphorylation. Strongly decreases repressor activity on E-cadherin/CDH1 and CLDN1 promoters. Increases protein stability. Affects function in cell survival. Abolishes phosphorylation in the serine-rich region%3B when associated with A-104 and A-107. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19923321;Dbxref=PMID:19923321	
O95863	UniProtKB	Mutagenesis	92	92	.	.	.	Note=Does not affect repressor activity on E-cadherin/CDH1 promoter. S->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19923321;Dbxref=PMID:19923321	
O95863	UniProtKB	Mutagenesis	96	96	.	.	.	Note=Abolishes recognition and ubiquitination by BTRC which increases steady state level and half-life. Preferentially localizes to the nucleus. Induces a more aggressive tissue invasion program. Lower sensitivity to BTRC-triggered degradation%2C impairs phosphorylation by GSK3B and does not affect NOTCH1-induced degradation%3B when associated with A-100. Lower sensitivity to BTRC-triggered degradation%2C impaired phosphorylation by GSK3B and loss of cytoplasmic localization%3B when associated with A-100%3B A-107%3B A-111%3B A-115 and A-119. S->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15448698,ECO:0000269|PubMed:15647282,ECO:0000269|PubMed:20305697,ECO:0000269|PubMed:22128911;Dbxref=PMID:15448698,PMID:15647282,PMID:20305697,PMID:22128911	
O95863	UniProtKB	Mutagenesis	98	98	.	.	.	Note=No change. Complete loss of sensitivity to FBXL14- and BTRC-triggered degradation and loss of ability to repress E-cadherin/CDH1%3B when associated with R-137 and R-146. K->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16096638,ECO:0000269|PubMed:19955572;Dbxref=PMID:16096638,PMID:19955572	
O95863	UniProtKB	Mutagenesis	100	100	.	.	.	Note=Lower sensitivity to BTRC-triggered degradation and impaired phosphorylation by GSK3B%3B when associated with A-96. Lower sensitivity to BTRC-triggered degradation%2C impaired phosphorylation by GSK3B and loss of cytoplasmic localization%3B when associated with A-96%3B A-107%3B A-111%3B A-115 and A-119. Does not affect NOTCH1-induced degradation%3B when associated with A-96. Abolishes phosphorylation at S-96. S->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15448698,ECO:0000269|PubMed:20305697,ECO:0000269|PubMed:22128911;Dbxref=PMID:15448698,PMID:20305697,PMID:22128911	
O95863	UniProtKB	Mutagenesis	104	104	.	.	.	Note=Increases protein stability%2C does not affect repressor activity on E-cadherin/CDH1 promoter%2C preferentially localizes to the nucleus%2C induces a more aggressive tissue invasion program and impairs phosphorylation by GSK3B%2C binding to BTRC and ubiquitination%3B when associated with A-107. Impairs phosphorylation in the serine-rich domain/region%3B when associated with A-92 and A-107. Abolishes phosphorylation at S-96. S->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15647282,ECO:0000269|PubMed:19923321,ECO:0000269|PubMed:20305697;Dbxref=PMID:15647282,PMID:19923321,PMID:20305697	
O95863	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Lower sensitivity to BTRC-triggered degradation%2C impaired phosphorylation by GSK3B and loss of cytoplasmic localization%3B when associated with A-111%3B A-115 and A-119. Lower sensitivity to BTRC-triggered degradation%2C impaired phosphorylation by GSK3B and loss of cytoplasmic localization%3B when associated with A-96%3B A-100%3B A-111%3B A-115 and A-119. Increases protein stability%2C does not affect repressor activity on E-cadherin promoter%2C preferentially localizes to the nucleus%2C induces a more aggressive tissue invasion program and impairs phosphorylation by GSK3B%2C binding to BTRC and ubiquitination%3B when associated with A-104. Impairs phosphorylation in the serine-rich region%3B when associated with A-92 and A-104. Abolishes phosphorylation at S-96. S->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15448698,ECO:0000269|PubMed:15647282,ECO:0000269|PubMed:19923321,ECO:0000269|PubMed:20305697;Dbxref=PMID:15448698,PMID:15647282,PMID:19923321,PMID:20305697	
O95863	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Predominantly localized to the cytoplasm%3B when associated with E-111%3B E-115 and E-119. S->E;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15448698,ECO:0000269|PubMed:15647282,ECO:0000269|PubMed:19923321,ECO:0000269|PubMed:20305697;Dbxref=PMID:15448698,PMID:15647282,PMID:19923321,PMID:20305697	
O95863	UniProtKB	Mutagenesis	111	111	.	.	.	Note=Lower sensitivity to BTRC-triggered degradation%2C impaired phosphorylation by GSK3B and loss of cytoplasmic localization%3B when associated with A-107%3B A-115 and A-119. Lower sensitivity to BTRC-triggered degradation%2C impaired phosphorylation by GSK3B and loss of cytoplasmic localization%3B when associated with A-96%3B A-100%3B A-107%3B A-115 and A-119. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15448698;Dbxref=PMID:15448698	
O95863	UniProtKB	Mutagenesis	111	111	.	.	.	Note=Predominantly localized to the cytoplasm%3B when associated with E-107%3B E-115 and E-119. S->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15448698;Dbxref=PMID:15448698	
O95863	UniProtKB	Mutagenesis	115	115	.	.	.	Note=Lower sensitivity to BTRC-triggered degradation%2C impaired phosphorylation by GSK3B and loss of cytoplasmic localization%3B when associated with A-107%3B A-111 and A-119. Lower sensitivity to BTRC-triggered degradation%2C impaired phosphorylation by GSK3B and loss of cytoplasmic localization%3B when associated with A-96%3B A-100%3B A-107%3B A-111 and A-119. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15448698;Dbxref=PMID:15448698	
O95863	UniProtKB	Mutagenesis	115	115	.	.	.	Note=Predominantly localized to the cytoplasm%3B when associated with E-107%3B E-111 and E-119. S->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15448698;Dbxref=PMID:15448698	
O95863	UniProtKB	Mutagenesis	119	119	.	.	.	Note=Lower sensitivity to BTRC-triggered degradation%2C impaired phosphorylation by GSK3B and loss of cytoplasmic localization%3B when associated with A-107%3B A-111 and A-119. Lower sensitivity to BTRC-triggered degradation%2C impaired phosphorylation by GSK3B and loss of cytoplasmic localization%3B when associated with A-96%3B A-100%3B A-107%3B A-111 and A-115. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15448698;Dbxref=PMID:15448698	
O95863	UniProtKB	Mutagenesis	119	119	.	.	.	Note=Predominantly localized to the cytoplasm%3B when associated with E-107%3B E-111 and E-115. S->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15448698;Dbxref=PMID:15448698	
O95863	UniProtKB	Mutagenesis	137	137	.	.	.	Note=Lower sensitivity to FBXL14-triggered degradation. Lower sensitivity to FBXL14-triggered degradation%3B when associated with R-146. Complete loss of sensitivity to FBXL14- and BTRC-triggered degradation and loss of ability to repress E-cadherin%3B when associated with R-98 and R-146. K->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16096638,ECO:0000269|PubMed:19955572;Dbxref=PMID:16096638,PMID:19955572	
O95863	UniProtKB	Mutagenesis	146	146	.	.	.	Note=Lower sensitivity to FBXL14-triggered degradation. Lower sensitivity to FBXL14-triggered degradation%3B when associated with R-137. Complete loss of sensitivity to FBXL14- and BTRC-triggered degradation%3B when associated with R-98 and R-137. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19955572;Dbxref=PMID:19955572	
O95863	UniProtKB	Mutagenesis	151	152	.	.	.	Note=Does not affect binding to KPNB1%2C KPNA2%2C IPO7 or TNPO1. RK->EE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19386897;Dbxref=PMID:19386897	
O95863	UniProtKB	Mutagenesis	156	156	.	.	.	Note=Abolishes binding to KPNB1%2C KPNA2%2C IPO7 and TNPO1 and nuclear localization. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19386897;Dbxref=PMID:19386897	
O95863	UniProtKB	Mutagenesis	161	161	.	.	.	Note=Does not affect binding to KPNB1%2C KPNA2%2C IPO7 or TNPO1. No change in subcellular localization. Impairs binding to KPNB1%2C KPNA2%2C IPO7 and TNPO1 and abolishes nuclear localization%2C DNA binding and repressor activity on E-cadherin/CDH1 promoter%3B when associated with E-170. Abolishes binding to KPNB1%2C KPNA2%2C IPO7 and TNPO1 and nuclear localization%3B when associated with E-187 and/or E-220. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19386897;Dbxref=PMID:19386897	
O95863	UniProtKB	Mutagenesis	170	170	.	.	.	Note=Does not affect binding to KPNB1%2C KPNA2%2C IPO7 or TNPO1. No change in subcellular localization. Impairs binding to KPNB1%2C KPNA2%2C IPO7 and TNPO1 and abolishes nuclear localization%2C DNA binding and repressor activity on E-cadherin/CDH1 promoter%3B when associated with E-161. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19386897;Dbxref=PMID:19386897	
O95863	UniProtKB	Mutagenesis	182	182	.	.	.	Note=Impairs binding to KPNB1%2C IPO7 and TNPO1 and abolishes binding to KPNA2. Localizes to cytoplasm and nucleus. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19386897;Dbxref=PMID:19386897	
O95863	UniProtKB	Mutagenesis	187	187	.	.	.	Note=Does not affect binding to KPNB1%2C KPNA2%2C IPO7 or TNPO1. Impairs binding to KPNB1%2C KPNA2%2C IPO7 and TNPO1 and abolishes nuclear localization%2C DNA binding and repressor activity on E-cadherin/CDH1 promoter%3B when associated with E-191. Abolishes binding to KPNB1%2C KPNA2%2C IPO7 and TNPO1 and nuclear localization%3B when associated with E-161 and/or E-220. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19386897;Dbxref=PMID:19386897	
O95863	UniProtKB	Mutagenesis	191	191	.	.	.	Note=Mildly reduces binding to KPNB1 and nuclear import. Strongly reduces binding to KPNB1 and nuclear import%3B when associated with A-193. Loss of binding to KPNB1 and nuclear import%3B when associated with A-193 and A-196. R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24699649;Dbxref=PMID:24699649	
O95863	UniProtKB	Mutagenesis	191	191	.	.	.	Note=Mildly reduces binding to KPNB1. Does not affect binding to KPNA2%2C IPO7 or TNPO1. R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19386897;Dbxref=PMID:19386897	
O95863	UniProtKB	Mutagenesis	193	193	.	.	.	Note=Mildly reduces binding to KPNB1 and nuclear import. Strongly reduces binding to KPNB1 and nuclear import%3B when associated with E-191. Loss of binding to KPNB1 and nuclear import%3B when associated with E-191 and A-196. W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24699649;Dbxref=PMID:24699649	
O95863	UniProtKB	Mutagenesis	196	196	.	.	.	Note=Loss of binding to KPNB1 and nuclear import%3B when associated with E-191 and A-193. Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24699649;Dbxref=PMID:24699649	
O95863	UniProtKB	Mutagenesis	203	203	.	.	.	Note=Abolishes LATS2 phosphorylation. Does not affect binding to LATS2. Reduces protein stability. Equally distributed between nucleus and cytoplasm. Increases capacity to associate with nuclear pore importins. Unable to accumulate in the nucleus. Does not abrogate function. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21952048;Dbxref=PMID:21952048	
O95863	UniProtKB	Mutagenesis	203	203	.	.	.	Note=Exclusively localizes to the cytoplasm. Reduces capacity to associate with nuclear pore importins. Unable to enter the nucleus. Does not abrogate function. T->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21952048;Dbxref=PMID:21952048	
O95863	UniProtKB	Mutagenesis	210	210	.	.	.	Note=Impairs binding to KPNB1%2C IPO7 and TNPO1 and abolishes binding to KPNA2. Localizes to cytoplasm and nucleus. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19386897;Dbxref=PMID:19386897	
O95863	UniProtKB	Mutagenesis	215	215	.	.	.	Note=Impairs binding to KPNB1%2C KPNA2%2C IPO7 and TNPO1. No change in subcellular localization. R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19386897;Dbxref=PMID:19386897	
O95863	UniProtKB	Mutagenesis	220	220	.	.	.	Note=Does not affect binding to KPNB1%2C KPNA2%2C IPO7 or TNPO1. No change in subcellular localization. Impairs binding to KPNB1%2C KPNA2%2C IPO7 and TNPO1%3B when associated with E-222 and E-224. Impairs binding to KPNB1%2C KPNA2%2C IPO7 and TNPO1 and abolishes nuclear localization%2C DNA binding and repressor activity on E-cadherin/CDH1 promoter%3B when associated with E-224. Abolishes binding to KPNB1%2C KPNA2%2C IPO7 and TNPO1 and nuclear localization%3B when associated with E-161 and/or E-187. R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19386897;Dbxref=PMID:19386897	
O95863	UniProtKB	Mutagenesis	222	222	.	.	.	Note=Does not affect binding to KPNB1%2C KPNA2%2C IPO7 or TNPO1. No change in subcellular localization. Impairs binding to KPNB1%2C KPNA2%2C IPO7 and TNPO1%3B when associated with E-220 and E-224. N->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19386897;Dbxref=PMID:19386897	
O95863	UniProtKB	Mutagenesis	224	224	.	.	.	Note=Does not affect binding to KPNB1%2C KPNA2%2C IPO7 or TNPO1. No change in subcellular localization. Impairs binding to KPNB1%2C KPNA2%2C IPO7 and TNPO1%3B when associated with E-220 and E-222. Impairs binding to KPNB1%2C KPNA2%2C IPO7 and TNPO1 and abolishes nuclear localization%2C DNA binding and repressor activity on E-cadherin/CDH1 promoter%3B when associated with E-220. R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19386897;Dbxref=PMID:19386897	
O95863	UniProtKB	Mutagenesis	224	224	.	.	.	Note=Mildly reduces binding to KPNB1 and nuclear import. Strongly reduces binding to KPNB1 and nuclear import%3B when associated with A-228. R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24699649;Dbxref=PMID:24699649	
O95863	UniProtKB	Mutagenesis	228	228	.	.	.	Note=Very minor effect on binding to KPNB1 and nuclear import. Strongly reduces binding to KPNB1 and nuclear import%3B when associated with E-224. Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24699649;Dbxref=PMID:24699649	
O95863	UniProtKB	Mutagenesis	232	235	.	.	.	Note=Does not affect binding to KPNB1%2C KPNA2%2C IPO7 or TNPO1. DVKK->KVEE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19386897;Dbxref=PMID:19386897	
O95863	UniProtKB	Mutagenesis	238	238	.	.	.	Note=Impairs binding to KPNB1 and IPO7 and abolishes binding to KPNA2 and TNPO1 and nuclear localization. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19386897;Dbxref=PMID:19386897	
O95863	UniProtKB	Mutagenesis	239	239	.	.	.	Note=Does not affect binding to KPNB1%2C KPNA2%2C IPO7%2C TNPO1 or DNA. Q->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19386897;Dbxref=PMID:19386897	
O95863	UniProtKB	Mutagenesis	246	246	.	.	.	Note=Decreases repression activity on E-cadherin/CDH1%2C occludin and aromatase promoters. Preferentially localizes to the cytoplasm. Abolishes phosphorylation by PAK1. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15833848;Dbxref=PMID:15833848	
O95863	UniProtKB	Mutagenesis	247	247	.	.	.	Note=Mildly reduces binding to KPNB1 and nuclear import. R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24699649;Dbxref=PMID:24699649	
O95863	UniProtKB	Sequence conflict	46	46	.	.	.	Note=P->L;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O95863	UniProtKB	Sequence conflict	154	154	.	.	.	Note=F->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O95863	UniProtKB	Helix	3	5	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2Y48	
O95863	UniProtKB	Turn	157	159	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3W5K	
O95863	UniProtKB	Beta strand	163	165	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3W5K	
O95863	UniProtKB	Helix	166	173	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3W5K	
O95863	UniProtKB	Helix	174	176	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3W5K	
O95863	UniProtKB	Beta strand	183	185	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3W5K	
O95863	UniProtKB	Beta strand	188	191	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3W5K	
O95863	UniProtKB	Helix	192	200	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3W5K	
O95863	UniProtKB	Turn	211	213	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3W5K	
O95863	UniProtKB	Beta strand	216	219	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3W5K	
O95863	UniProtKB	Helix	220	227	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3W5K	
O95863	UniProtKB	Turn	239	241	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3W5K	
O95863	UniProtKB	Beta strand	244	247	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3W5K	
O95863	UniProtKB	Helix	248	256	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3W5K	
